“…In temperate regions of Australia, and in similar climatic regions globally, pollens from temperate grasses (such as ryegrass) are major drivers of seasonal allergic rhinitis (SAR) and asthma risks, including epidemic thunderstorm asthma. [1][2][3][4] The effectiveness of temperate grass pollen allergen immunotherapy (AIT) has been wellcharacterized in SAR populations from the northern hemisphere, with evidence available from a number of large, double-blind, placebocontrolled, randomized trials for the short-and long-term treatment benefits of standardized AIT products. 5 However, there have been comparatively few studies of the effectiveness of temperate grass pollen AIT treatments in SAR patients from the southern hemisphere, who are frequently polysensitized to both temperate and subtropical grass pollens.…”